Lynne is the Founder and Managing Partner of Define Ventures, an early-stage venture capital firm focused on investing in digital health companies redefining healthcare. Define Ventures focuses on incubation, seed, Series A, and Series B stage digital health startups. She has partnered with entrepreneurs to help them build category defining digital health companies, such as Livongo (NASDAQ:LVGO), HIMS (NASDAQ:HIMS), etc. Prior to Define Ventures, Lynne’s experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins focused on digital health and connected devices early-stage investing.

Before Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles launching over ten product families in the US and internationally. She was responsible for building the global commercial strategy and therapy development as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. Lynne also worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion-dollar acquisitions and sell side transactions in various industries.